Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

No Benefit of Colchicine in All-Comers PCI

Shelley Wood

November 17, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Presentation

Predicting Major Adverse Events in Patients With Acute MI

August 13, 2019

News Daily News

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

Marcus A. Banks

August 13, 2019

News Daily News

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Caitlin E. Cox

July 25, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

Advertisement

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

No Benefit of Colchicine in All-Comers PCI

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Recurrent Events Common Among Young Patients With CAD

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Predicting Major Adverse Events in Patients With Acute MI

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content